Huerne Katherine, Palmour Nicole, Wu Angela Ruohao, Beck Stephan, Berner Alison, Siebert Reiner, et al. Auditing the Editor: A Review of Key Translational Issues in Epigenetic Editing. The CRISPR Journal. 2022; Available from: https://www.liebertpub.com/doi/10.1089/crispr.2021.0094
Arych Mykhailo, Joly Yann. Genetic Discrimination in Access to Life Insurance: Does Ukrainian Legislation Offer Sufficient Protection against the Adverse Consequences of the Genetic Revolution to Insurance Applicants?. Laws. 2021;11(1):2. Available from: https://www.mdpi.com/2075-471X/11/1/2
Lenartz Andrea, Scherer Aaron M., Uhlmann Wendy R., Suter Sonia M., Anderson Hartley Colleen, Prince Anya E. R. The persistent lack of knowledge and misunderstanding of the Genetic Information Nondiscrimination Act (GINA) more than a decade after passage. Genetics in Medicine. 2021;23(12):2324-2334. Available from: https://www.nature.com/articles/s41436-021-01268-w
Tolwinski Kasia, Madden Diana, Wagner Jennifer K. A genetic imaginary for social justice: The rhetoric of genomic medicine as exceptional, ordinary, and ethical obligation. SSM - Qualitative Research in Health. 2022;:100120. Available from: https://www.sciencedirect.com/science/article/pii/S2667321522000828
Rebbeck Timothy R., Mahal Brandon, Maxwell Kara N., Garraway Isla P., Yamoah Kosj. The distinct impacts of race and genetic ancestry on health. Nat Med. 2022;28(5):890-893. Available from: https://www.nature.com/articles/s41591-022-01796-1
Genetic Alliance JP, Japan Federation of Cancer Patient Groups. Joint statement calling for legislation to prevent discrimination and social disadvantage due to genetic and genomic information.. 2022. Available from: https://gdo.global/docs/April6-GDO_En_PatientAssociations_Statement.pdf
Japanese Association of Medical Sciences and the Japanese Medical Science Federation, Japan Medical Association. Joint Statement on "Preventing Unfair Discrimination and Social Disadvantage by Genetic and Genomic Information”. 2022. Available from: https://gdo.global/docs/April6_GDO_En_MedicalAssociations_Statement.pdf
The Genetic Discrimination Observatory (GDO) is a unique network of researchers and other stakeholders dedicated to researching and preventing discrimination based on genomic and other omic data worldwide.
GDO Project Team
International Expert Panel
These FAQs have been developed by the research team to provide general information about genetic discrimination.
If you have been the victim of genetic discrimination and you want to share your story with the GDO.
With the help of our collaborators, the GDO provides several maps representing the state of genetic discrimination in real time around the world.
To accomplish its goal of serving as a comprehensive online resource to monitor and prevent genetic discrimination, the GDO provides access to the following resources: Tool Boxes, Policies and Publications.
Genetic discrimination involves treating differently and negatively or unfairly profiling an individual relative to the rest of the population on the basis of actual or presumed genetic characteristics.
Refer to our FAQs for a more extensive definition »
The Genetic Discrimination Observatory (GDO) is a unique network of researchers and other stakeholders dedicated to researching and preventing discrimination based on genomic and other omic data worldwide. The GDO serves as a comprehensive online resource that offers a collaborative platform providing access to information and tools needed to monitor and prevent genetic discrimination.
Specific aspects of the GDO include a secure management system; integrated registration for participants; and a database of projects, new developments, and events. Our overall approach is framed by recognized human rights principles including respect for autonomy, dignity, privacy, the right to science, and the right to know/right not to know.
1. Consultations with key stakeholders for tools, elements and content;
2. Content is reviewed for relevance and quality;
3. Lay summaries of all scientific materials made available for non-experts;
4. Governance structure and decision process are transparent and subject to ethical guidelines and oversight.